Smith & Nephew Plc
16 June 2004
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1. Name of company
Smith & Nephew plc
2. Name of director
Sir Christopher O'Donnell
3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18 or in respect of a non-beneficial
interest
Shareholder above
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified)
Abacus Corporate Trustee Ltd
5. Please state whether notification relates to a person(s) connected with the
director named in 2 above and identify the connected person(s)
Not applicable
6. Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary
Purchase of shares under Smith & Nephew 2004 Co-Investment Plan
7. Number of shares / amount of stock acquired
13,057
8. Percentage of issued class
0.0013%
9. Number of shares/amount of stock disposed
10. Percentage of issued class
11. Class of security
Ordinary shares of 12 2/9p
12. Price per share
583.32p
13. Date of transaction
16 June 2004
14. Date company informed
16 June 2004
15. Total holding following this notification
177,468
16. Total percentage holding of issued class following this notification
0.019%
If a director has been granted options by the company please complete the
following boxes.
17. Date of grant
18. Period during which or date on which exercisable
19. Total amount paid (if any) for grant of the option
20. Description of shares or debentures involved: class, number
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at time of exercise
22. Total number of shares or debentures over which options held following this
notification
23. Any additional information
Under the Co-Investment Plan participants invest cash or an equivalent value of
an existing ordinary shareholding and in 3 years time will receive a matching
award of ordinary shares for a nil cost; the level of matching award will depend
on certain performance conditions being met. Cash invested by participants is
used to acquire shares which are held on the participants' behalf by the trustee
of the Plan.
24. Name of contact and telephone number for queries
Clare Carpenter 020 7960 2316
25. Name and signature of authorised company official responsible for making
this notification
K Cummins 020 7960 2251
Date of Notification
16 June 2004
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.